In VivoHarper told In Vivo that the big challenges for VCs today are how to conduct due diligence in an era of accelerating scientific discovery; declining trust between VCs and start-ups, accentuated by t
In VivoCompany Changes ADENT , John To: Neogen Corp. , CEO (July) From: Animal Health International, CEO Phone: 517-372-9200 ARENA , Paul To: Parallax Health Sciences Inc. , CEO (July) From: Arena